Lilly Foundayo (orforglipron) 17.2 mg shows greater weight loss and A1C vs oral semaglutide 25 mg

Lilly says Foundayo (orforglipron) 17.2 mg showed greater weight loss and A1C reduction than oral semaglutide 25 mg among adults with type 2 diabetes in a new indirect treatment comparison.